If Polidocanol in Not FDA Approved, How Can It Be Used in the U.S.?

Doctor Answers 17


Is approved and has been used in U.S. And my practice for many years.  I get amazing results unlike any other treatment with this.  

Los Angeles Dermatologic Surgeon
4.9 out of 5 stars 52 reviews

Polidoconol is now FDA approved

Polidoconol is not FDA approved for us in the United States.  it is an excellent product.  I use both Asclera and Sotradecol in my practice.

Mitchel P. Goldman, MD
San Diego Dermatologic Surgeon
4.9 out of 5 stars 25 reviews

Asclera Approved

Asclera (Piloocanol) was recently approverd for use in the US after a long patent fight. It was used frequently in the 60's and 70's (80's?) by many vascular surgeons but there was a disagreement  about-wait for it- money and it was taken off the market. it was "smuggled" in by vascular surgeons for subcutaneous injection of spider telangiectasia and reticular veins for years from both Mexico and Europe as it was significantly more effective than either Sodium morrhuate or Sodium Tetradecol in many surgeons' opinions.

I have found it to be useful but it works better in combination with other therapy such as IR/RF laser. Hopet his helps.

Jeffrey W. Kronson, MD
Los Angeles General Surgeon


Asclera (Polidocanol) is FDA approved in the US. In my experience, it works better than any of the other sclerosing agents available in the US market, and is much more comfortable.

Jon M. Grazer, MD, MPH, FACS
Newport Beach Plastic Surgeon
5.0 out of 5 stars 5 reviews

Asclera - FDA Approved for spider veins and reticular veins

Asclera was FDA approved in the Spring of 2010 in two concentrations. The 0.5% solution is used to treat spider veins while the 1% is used to treat reticular veins, small (1-3 mm) blue veins on the legs. Polidocanol injections are well tolerated with a decrease incidence of pain, ulcerations, and post-sclerotherapy pigmentation.

Jennifer Peterson, MD
Houston Dermatologist
4.3 out of 5 stars 17 reviews

FDA approved March 2010

I only used FDA-approved products in our practice and we welcome the FDA approval of polidocanol which may offer better comfort and decreased side effects including ulceration and dyspigmentation follownig sclerotherapy treatment.

Melanie D. Palm, MD (account suspended)
San Diego Dermatologic Surgeon
4.9 out of 5 stars 23 reviews


Polidocanol is safe and is now FDA approved. It has a much lower side effect profile than sotradecol.

Timothy Mountcastle, MD
Ashburn Plastic Surgeon
4.3 out of 5 stars 29 reviews

Polidocanol received FDA approval

in March 2010 and is called Asclera.  Asclera has been my sclerosing agent of choice for several reasons:  it comes in individually packaged ampules with expiration dates and lot numbers so there are no concerns about contamination, expiration and exact concentration.  It has an long record of safety and efficacy as it has been used by physicians in Europe for many years.  The chance of temporary post-inflammatory hyperpigmentation with Asclera is less than with other sclerosing agents, e.g. sotradechol.     

Felix Kuo, MD
Long Island Dermatologist
5.0 out of 5 stars 5 reviews

Polidocanol for sclerotherapy

Polidocanol now (belatedly) FDA approved, and marketed by Bioform/Merz Pharmaceuticals.  Excellent product.

Steve Laverson, MD
San Diego Plastic Surgeon
4.9 out of 5 stars 47 reviews

Polidocanol for Leg Vein Injections

I have been using Polidocanol for leg vein injections for over 25 years because I feel that it is the best product out there for this treatment. It works as well as other Injectables, is virtually painless, and has a remarkable safety profile. It was finally approved for this use by the FDA in 2010.

Mitchell Schwartz, MD
South Burlington Dermatologic Surgeon
4.7 out of 5 stars 12 reviews

These answers are for educational purposes and should not be relied upon as a substitute for medical advice you may receive from your physician. If you have a medical emergency, please call 911. These answers do not constitute or initiate a patient/doctor relationship.